Back to video list Back to Home Is there a value of initiating a long-acting injectable if adherence might not be a concern? You may also like Mental Health Congress highlights Article Is the DSM still relevant to psychiatry? Depression Schizophrenia Congress highlights Article Highlights from the 36th European College of Neuropsychopharmacology – ECNP – Congress Depression Schizophrenia Article Making primary care count in mental health provision Schizophrenia Satellite symposium Article Cognitive impairment, as a key symptom of schizophrenia